USMF logo

Institutional Repository in Medical Sciences
of Nicolae Testemitanu State University of Medicine and Pharmacy
of the Republic of Moldova
(IRMS – Nicolae Testemitanu SUMPh)

Biblioteca Stiintifica Medicala
DSpace

University homepage  |  Library homepage

 
 
Please use this identifier to cite or link to this item: http://hdl.handle.net/20.500.12710/7459
Title: Sindromul hepatopulmonar
Other Titles: Hepatopulmonary syndrome
Authors: Tcaciuc, E.
Keywords: liver cirrhosis;portal hypertension;hepatopulmonary syndrome
Issue Date: 2014
Publisher: The Scientific Medical Association of the Republic of Moldova
Citation: TCACIUC, E. Sindromul hepatopulmonar. In: Curierul Medical. 2014, vol. 57, no 6, pp. 58-66. ISSN 1875-0666.
Abstract: Background: Hepatopulmonary syndrome (HPS) is an important complication of liver cirrhosis. It is due to vasodilation and angiogenesis in the pulmonary vascular bed, which lead to ventilation-perfusion mismatching, diffusion limitation to oxygen exchange, and arteriovenous shunting. Pulmonary vasodilation in experimental HPS is mediated by a number of endogenous vasoactive molecules, including endothelin-1 (ET-1) and nitric oxide (NO). Liver injury stimulates release of ET-1, which increases expression of ETB receptors in pulmonary endothelial cells. Activation of these receptors results in the upregulation of endothelial NO synthesis (eNOS) and subsequent increased production of NO, which diffuses into vascular smooth muscle, causing vasodilation. In addition, increased phagocytosis of bacterial endotoxin in the lung promotes activation of inducible NO synthase (iNOS), which also contributes toward increased NO production. Bacterial translocation and subsequent monocyte accumulation may also stimulate pulmonary angiogenesis in HPS, which may be partly controlled by genetic factors. Conclusion: However, there remains a need for more human experimental data to support the development of new therapies targeting these proposed mechanisms. Despite promising outcomes from treatment of HPS with several drugs, results can not be generalized to all patients due to the lack of randomized trials. Promising drugs are considered Pentoxifylline, Methylene blue and Mycophenolate mofetil. Currently the most effective treatment is liver transplantation.
metadata.dc.relation.ispartof: Curierul Medical
URI: http://repository.usmf.md/handle/20.500.12710/7459
http://moldmedjournal.md/wp-content/uploads/2016/09/Cm-6-2014-Electronic-version.pdf
ISSN: 1875-0666
Appears in Collections:Curierul Medical, 2014, Vol. 57, Nr. 6

Files in This Item:
File Description SizeFormat 
Hepatopulmonary_syndrome.pdf1.12 MBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

 

Valid XHTML 1.0! DSpace Software Copyright © 2002-2013  Duraspace - Feedback